Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifamycine for complications after third molar surgery
NCT04349579Phase 4Unknown
- Sponsor
- Van Yuzuncu Yil University
- Start
- Nov 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifamycin SV-MMX in postoperative pain, edema, trismus, sponsored by Van Yuzuncu Yil University. Status: unknown.
02
Drugs
rifamycin SV-MMX
03
Conditions
postoperative painedematrismus
Beyond the preview
Go deeper on NCT04349579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349579.